Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for HumanPlasmodium vivax Malaria

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Infection and Immunity

• Publication date

  1998-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.66.4.1500-1506.1998PMID 9529073PMCID PMC108080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response.

  1997influential reference
• A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

  1997cited by this paper
• A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria

  1996cited by this paper
• Chloroquine resistant Plasmodium vivax malaria in India

  1996cited by this paper
• The Plasmodium cynomolgi merozoite surface protein 1 C-terminal sequence and its homologies with other Plasmodium species.

  1995cited by this paper
• Vivax malaria resistant to chloroquine: case reports from Bombay.

  1995cited by this paper
• Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus Monkeys

  1995cited by this paper
• Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences.

  1994cited by this paper
• Immunization against malaria with a recombinant protein

  1994cited by this paper
• Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus.

  1994cited by this paper
• Evolutionary relatedness of some primate models of Plasmodium.

  1993cited by this paper
• High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.

  1993cited by this paper
• A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice

  1993cited by this paper
• The major merozoite surface protein as a malaria vaccine target.

  1993cited by this paper
• CHAPTER 3 – Plasmodia of Nonhuman Primates

  1993cited by this paper
• Merozoite surface antigen-I of plasmodium.

  1993cited by this paper
• Chloroquine resistance in Plasmodium vivax: the first case in Brazil.

  1992cited by this paper
• Cerebral symptoms with P. vivax malaria.

  1992cited by this paper
• Chloroquine-resistant Plasmodium vivax in Papua New Guinea.

  1992cited by this paper
• Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (Pf MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity

  1992influential reference
• Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species.

  1991cited by this paper
• Cloning of the Plasmodium vivax Duffy receptor.

  1991cited by this paper
• Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential

  1991cited by this paper
• New Generation Vaccines

  1990cited by this paper
• Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica.

  1990cited by this paper
• The precursor to major merozoite surface antigens: structure and role in immunity.

  1988cited by this paper
• Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.

  1988cited by this paper
• Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

  1987cited by this paper
• The circumsporozoite gene of the Plasmodium cynomolgi complex.

  1987cited by this paper
• Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation.

  1987cited by this paper
• Demonstration of antigenic polymorphism in Plasmodium vivax malaria with a panel of 30 monoclonal antibodies

  1987cited by this paper
• Evolutionary relatedness of Plasmodium species as determined by the structure of DNA.

  1984cited by this paper
• Ruptured spleen in a malarious area: with emphasis on conservative management in both adults and children.

  1982cited by this paper
• Primate malarias.

  1974cited by this paper
• Malaria Parasites and Other Haemosporidia

  1967cited by this paper
• Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium.

  1966cited by this paper
• Two New Malaria Parasites, Plasmodium cynomolgi ceylonensis subsp. nov. and Plasmodium fragile sp. nov., from Monkeys in Ceylon.

  1965cited by this paper
• Criteria of Immunity and Susceptibility in Naturally Induced Vivax Malaria Infections.

  1942cited by this paper

• Modular Display of Plasmodium yoelii Circumsporozoite Surface Protein and Merozoite Surface Protein-1 on Norovirus-like Particles.

  2024cites this paper
• Plasmodium vivax vaccine: What is the best way to go?

  2023cites this paper
• Humoral immune response and changes in peritoneal cell populations in rats immunized against two Leptospira serovars; serovar patoc and serovar pyrogenes

  2023influential citation
• Potential role of vaccines in elimination of Plasmodium vivax.

  2022cites this paper
• Characterization of antigens of Enterobius vermicularis (pinworm) eggs

  2022cites this paper
• A recombinant baculovirus vector vaccine (BacMCP) against the infectious spleen and kidney necrosis virus (ISKNV).

  2022cites this paper
• Progress towards the development of a P. vivax vaccine

  2021influential citation
• The immunology of Plasmodium vivax malaria

  2020cites this paper
• Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119

  2020cites this paper
• Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.

  2020cites this paper
• Evaluation of Plasmodium vivax isolates in Thailand using polymorphic markers Plasmodium merozoite surface protein (PvMSP) 1 and PvMSP3

  2018cites this paper
• Genetic diversity and natural selection of Plasmodium knowlesi merozoite surface protein 1 paralog gene in Malaysia

  2018cites this paper
• Within-population genetic diversity and population structure of Plasmodium knowlesi merozoite surface protein 1 gene from geographically distinct regions of Malaysia and Thailand

  2018cites this paper
• Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal

  2017influential citation
• Advances in Malaria Research

  2016cites this paper
• Immunogenicity of a plasmid DNA vaccine encoding 42kDa fragment of Plasmodium vivax merozoite surface protein-1.

  2016cites this paper
• evelopment of vaccines for Plasmodium vivax malaria

  2016cites this paper
• Progress in development of malaria vaccines

  2016cites this paper
• Genetic and Structural Characterization of Serine Repeat Antigen (SERA) in the Human Malarial Parasite Plasmodium from Indian Isolates

  2015cites this paper
• A comparative study on worldwide genetic diversity and population structure analysis of Plasmodium vivax thrombospondin-related adhesive protein (PvTRAP) and its implications for the vivax vaccine design.

  2015cites this paper
• Development of vaccines for Plasmodium vivax malaria.

  2015cites this paper
• A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions

  2015cites this paper
• Plasmodium vivax: N-terminal diversity in the blood stage SERA genes from Indian isolates.

  2015cites this paper
• Cloning, overexpression and characterization of soluble 42kDa fragment of merozoite surface protein-1 of Plasmodium vivax.

  2014cites this paper
• Progress towards development of a vaccine forPlasmodium vivaxmalaria

  2014cites this paper
• Malaria vaccine development: over 40 years of trials and tribulations

  2014cites this paper
• does not evoke

  2014cites this paper
• Immunization with Purine Salvation Pathway Recombinant Enzymes Induces the Production Of Anti- Schistosoma Mansoni Immunoglobulines

  2013cites this paper
• The Plasmodium vivax Merozoite Surface Protein 1 Paralog Is a Novel Erythrocyte-Binding Ligand of P. vivax

  2013cites this paper
• Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants

  2012cites this paper
• AntigenCyRPA as Candidate Malaria Vaccine -Infected Mice Designates the falciparum Plasmodium Passive Immunoprotection of

  2012cites this paper
• Passive Immunoprotection of Plasmodium falciparum-Infected Mice Designates the CyRPA as Candidate Malaria Vaccine Antigen

  2012cites this paper
• Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens

  2012cites this paper
• Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays

  2011cites this paper
• Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka.

  2011cites this paper
• Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?

  2011cites this paper
• Suppression of Plasmodium cynomolgi in Rhesus Macaques by Coinfection with Babesia microti

  2010cites this paper
• Plasmodium vivax: immunological properties of tryptophan-rich antigens PvTRAg 35.2 and PvTRAg 80.6.

  2010cites this paper
• Phagocytic activity and pro-inflammatory cytokines production by the murine macrophage cell line J774A.1 stimulated by a recombinant BCG (rBCG) expressing the MSP1-C of Plasmodium falciparum.

  2010cites this paper
• Current status of Plasmodium vivax vaccine

  2010cites this paper
• High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar.

  2009cites this paper
• Wheat germ cell-free technology for accelerating the malaria vaccine research

  2009cites this paper
• The future for blood‐stage vaccines against malaria

  2009cites this paper
• Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria

  2008cites this paper
• New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.

  2008cites this paper
• Vacuna frente a la malaria: el gran reto para los países en vías de desarrollo

  2008cites this paper
• Plasmodium vivax: who cares?

  2008cites this paper
• Statistical Model To Evaluate In Vivo Activities of Antimalarial Drugs in a Plasmodium cynomolgi-Macaque Model for Plasmodium vivax Malaria

  2008cites this paper
• An update on the search for a Plasmodium vivax vaccine.

  2007cites this paper
• Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.

  2007cites this paper
• Structural studies on Plasmodium vivax merozoite surface protein-1.

  2007cites this paper
• Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.

  2007cites this paper
• Production of High-Affinity Human Monoclonal Antibody Fab Fragments to the 19-Kilodalton C-Terminal Merozoite Surface Protein 1 of Plasmodium falciparum

  2007cites this paper
• Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.

  2007cites this paper
• Recent independent evolution of msp1 polymorphism in Plasmodium vivax and related simian malaria parasites.

  2007cites this paper
• Expression, Purification and Characterization of a Recombinant Plasmodium Vivax Thrombospondin Related Adhesive Protein (PvTRAP)

  2006cites this paper
• Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).

  2006cites this paper
• Immune responses to asexual blood-stages of malaria parasites.

  2006cites this paper
• Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors

  2006cites this paper
• Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate.

  2006cites this paper
• Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19).

  2005cites this paper
• Malaria vaccines in development

  2005cites this paper
• Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.

  2005cites this paper
• Merozoite Surface Protein 1 of Plasmodium vivax Induces a Protective Response against Plasmodium cynomolgi Challenge in Rhesus Monkeys

  2005influential citation
• Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.

  2004cites this paper
• Vaccination for vivax malaria: targeting the invaders.

  2004cites this paper
• Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli

  2004cites this paper
• The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate.

  2004cites this paper
• Plasmodium vivax under the microscope: the Aotus model.

  2003cites this paper
• Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments.

  2003cites this paper
• Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate.

  2003cites this paper
• Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure.

  2003cites this paper
• Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression.

  2003cites this paper
• Current status of malaria vaccine development.

  2003cites this paper
• 2nd meeting on novel adjuvants currently in/close to human clinical testing. World Health Organization-Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5-7 June 2000.

  2002cites this paper
• Immunity to asexual blood stage malaria and vaccine approaches

  2002cites this paper
• Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.

  2002cites this paper
• Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys.

  2002cites this paper
• Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria1

  2002influential citation
• O desafio da malária: o caso brasileiro e o que se pode esperar dos progressos da era genômica

  2002cites this paper
• The malaria challenge: the Brazilian case and what can be expected from progress in genomics

  2002cites this paper
• Immunity to Blood Stage Malaria Antibody-Independent Protective Role in Merozoite Surface Protein 1 and Their Plasmodium yoelii 33-kDa Fragment of Identification of T Cell Epitopes on the

  2002influential citation
• Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria

  2002influential citation
• Immunogenic properties of the Plasmodium vivax vaccine candidate MSP119 expressed as a secreted non-glycosylated polypeptide from Pichia pastoris

  2002cites this paper
• Expression of Babesia equi Merozoite Antigen 1 in Insect Cells by Recombinant Baculovirus and Evaluation of Its Diagnostic Potential in an Enzyme-Linked Immunosorbent Assay

  2001cites this paper
• The Fate of Merozoites

  2001cites this paper
• Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked Plasmodium vivax Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in Escherichia coli

  2001cites this paper
• Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors.

  2001cites this paper
• Plasmodium vivax malaria vaccine development.

  2001cites this paper
• Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1.

  2001cites this paper
• Molecular insights into receptors used by malaria parasites for erythrocyte invasion

  2001cites this paper
• Immunosorbent Assay Diagnostic Potential in an Enzyme-Linked Baculovirus and Evaluation of Its Antigen 1 in Insect Cells by Recombinant Merozoite Babesia equi Expression of

  2001cites this paper
• Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii.

  2001cites this paper
• Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells

  2000cites this paper
• Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species

  2000cites this paper
• Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay Cohort Project.

  2000cites this paper
• Vaccin contre la malaria

  2000cites this paper
• Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119

  2000cites this paper
• Biochemical and Immunological Properties of a Viral Hybrid Particle Expressing the Plasmodium vivax Merozoite Surface Protein 1 C-terminal Region

  2000cites this paper
• Genetic Immunization of BALB/c mice with a Plasmid Bearing the Gene Coding for a Hybrid Merozoite Surface Protein 1-Hepatitis B Virus Surface Protein Fusion Protects Mice against Lethal Plasmodium chabaudi chabaudi PC1 Infection

  2000cites this paper